Aplastic anemia has been treated successfully since the 1970s with immunosuppressive therapy (ATG) and more recently with hematopietic cell transplantation. Unfortunately, some patients have a relapse where the disease characteristics and symptoms return after there’s been a period of remission. Others do not respond to one type of treatment and they have to try another method. This session will cover best practices in treating aplastic anemia that has relapsed or is refractory. This session is suitable for all patients, family members and caregivers.